Rapid Medical has announced that its Drivewire 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America throughout a limited commercial launch that began earlier this year.
The company has also announced the receipt of a CE mark under the European Medical Device Regulation (MDR), as presented this week at the 2025 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (3–5 September, Marseille, France).
“In my experience, the wire provides a unique combination of precision and support that simply hasn’t been possible with conventional technologies,” stated Erez Nossek (New York University [NYU] Langone, New York, USA). “It has become a reliable tool that allows us to approach any anatomy with greater efficiency and less time.”
As the “first” steerable 0.024-inch guidewire, Drivewire has quickly become a go-to technology in ischaemic stroke, aneurysms, and other complex neurovascular conditions, Rapid Medical claims. With its mechanically adjustable tip, physicians can shape and steer the wire in real time—enabling faster, more reliable access to distal vessels, minimising wire exchanges, and providing robust catheter support, the company also states in a recent press release.
In a North American multicentre analysis of 176 cases, the device successfully reached the target site in 94% of procedures with no device-related complications.
Rapid Medical’s release goes on to note that European clinicians are now preparing for adoption of the Drivewire device as well.
“It’s clear this technology can expedite our cases exponentially,” said Hozan Radhi (Örebro University Hospital, Örebro, Sweden), after receiving training on the product. “The ability to control the tip in real time opens new options for access, precision and support. I’m eager to integrate it into my daily practice and believe it will significantly change how we approach everyday cases.”
